Surender Juneja - Concepedia

Author

Surender Juneja

Also Known As

S Juneja, S K Juneja, S. JUNEJA, S. Juneja, S. K. JUNEJA, S. K. Juneja, S.K. Juneja, Sanjay Juneja, Shilpa Juneja, Shradha Juneja

134

Publications

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The Royal Melbourne Hospital St Vincent's Hospital Melbourne The University of Melbourne Monash Medical Centre

About

Surender Juneja is an author at Peter MacCallum Cancer Centre specializing in hematology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	735
2	Health Sciences	9	9	454
3	Cell Biology	2	2	74
4	Epidemiology	2	2	30
5	Public Health	1	1	16

Surender Juneja

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax Mary Ann Anderson, Constantine S. Tam, Thomas E. Lew, Blood	2017	174
The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement Janine Campbell, John F. Seymour, Jane Matthews, European Journal Of Haematology	2006	121
Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. Surender Juneja, M Wolf, I. A. Cooper Journal of Clinical Pathology Hematological MalignancyLymphoid NeoplasiaDiscordant HistologyBilateral Biopsy SpecimensMalignant Blood Disorder	1990	101
Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases. Surender Juneja, Michèle Imbert, H Jouault, Journal of Clinical Pathology Hematological MalignancyImmunohematologyRefractory AnaemiaRefractory CytopeniaBone Marrow Failure	1983	79
Cytogenetic analysis of 147 cases of non‐Hodgkin's lymphoma: non‐random chromosomal abnormalities and histological correlations Surender Juneja, Robyn Lukeis, Lihua Tan, British Journal of Haematology Cancer PathologyCytogeneticsImmunologyNon‐random Chromosomal AbnormalitiesPathology	1990	77
Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders Piers Blombery, Stephen Q. Wong, Chelsee Hewitt, Haematologica Mixed-phenotype Acute LeukemiaGeneticsPathologyHairy Cell LeukemiaDermatology	2011	73
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray Larissa Belov, Stephen P. Mulligan, Nicole Barber, British Journal of Haematology Mixed-phenotype Acute LeukemiaImmunologyPathologyImmunophenotypingAntibody Microarray	2006	68
Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma Janine Campbell, Jane Matthews, John F. Seymour, Annals of Oncology Lymphoid NeoplasiaOptimum Trephine LengthMedicineBone Marrow InvolvementMalignant Blood Disorder	2003	66
Altered Multidrug Resistance Phenotype Caused by Anthracycline Analogues and Cytosine Arabinoside in Myeloid Leukemia Xiu Feng Hu, Alison Slater, Phillip Kantharidis, Blood	1999	62
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Ashley P. Ng, Andrew H. Wei, Dinesh Bhurani, PubMed ImmunologyPathologyMarrow InvolvementImmunophenotypingPlasma Cells	2006	54

Page 1